Showing results (31-40 of 170) with videos related to

Sort By:
Pageof 17
Molecular Cancer Therapeutics|June 26, 2021
Current Development of Glioblastoma Therapeutic AgentsZilai Wang, Norton P Peet, Pin Zhang, et al.
The Journal of Biological Chemistry|January 30, 2004
The role of a conserved acidic residue in calcium-dependent protein folding for a low density lipoprotein (LDL)-A module: implications in structure and function for the LDL receptor superfamilyYing Guo, Xuemei Yu, Kayla Rihani, et al.
Virology Journal|June 12, 2009
Comparative analysis between a low pathogenic and a high pathogenic influenza H5 hemagglutinin in cell entryEmily Rumschlag-Booms, Ying Guo, Jizhen Wang, et al.
Plos One|November 7, 2013
Inhibition of influenza H7 hemagglutinin-mediated entryAleksandar Antanasijevic, Han Cheng, Duncan J Wardrop, et al.
European Journal of Medicinal Chemistry|July 25, 2020
Development of coumarine derivatives as potent anti-filovirus entry inhibitors targeting viral glycoproteinYinyi Gao, Han Cheng, Sameer Khan, et al.
Microbiology Spectrum|May 16, 2024
VLP-based model for the study of airborne viral pathogensMichael Caffrey, Nitin Jayakumar, Veronique Caffrey, et al.
Virologica Sinica|October 29, 2022
Revisiting influenza A virus life cycle from a perspective of genome balanceRuikun Du, Qinghua Cui, Zinuo Chen, et al.
Biochemistry|May 21, 2010
Alanine scanning mutagenesis of HIV-1 gp41 heptad repeat 1: insight into the gp120-gp41 interactionJayita Sen, Tianran Yan, Jizhen Wang, et al.
Virologica Sinica|December 11, 2012
The Role of the Charged Residues of the GP2 Helical Regions in Ebola Entry()Haiqing Jiang, Jizhen Wang, Balaji Manicassamy, et al.
Acta Pharmaceutica Sinica. B|May 18, 2021
SARS-CoV-2 cell entry and targeted antiviral developmentZinuo Chen, Ruikun Du, Jazmin M Galvan Achi, et al.
Pageof 17